SEC Comment Letter 0000000000-23-009571 to PRF Technologies Ltd. (PRFX)
PRF Technologies Ltd.
Date: Aug. 30, 2023 · CIK: 0001801834 · Accession: 0000000000-23-009571
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-274220
Letter
United States securities and exchange commission logo August 30, 2023 Ilan Hadar Chief Executive Officer PainReform Ltd. 65 Yigal Alon St. Tel Aviv, Israel 6744316 Re:PainReform Ltd. Registration Statement on Form F-1 Filed August 25, 2023 File No. 333-274220 Dear Ilan Hadar: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jason Drory at 202-551-8342 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Gary M. Emmanuel
Show Raw Text
United States securities and exchange commission logo
August 30, 2023
Ilan Hadar
Chief Executive Officer
PainReform Ltd.
65 Yigal Alon St.
Tel Aviv, Israel 6744316
Re:PainReform Ltd.
Registration Statement on Form F-1
Filed August 25, 2023
File No. 333-274220
Dear Ilan Hadar:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jason Drory at 202-551-8342 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Gary M. Emmanuel